Short Interest Summary: Can Zimmer Biomet Holdings Incorporated (NYSE:ZBH)’s Tomorrow be Different? The Stock Had Increase in Shorts

November 22, 2016 - By Marguerite Chambers   ·   0 Comments

Short Interest Summary: Can Zimmer Biomet Holdings Incorporated (NYSE:ZBH)’s Tomorrow be Different? The Stock Had Increase in Shorts

The stock of Zimmer Biomet Holdings Incorporated (NYSE:ZBH) registered an increase of 6.23% in short interest. ZBH’s total short interest was 4.82M shares in November as published by FINRA. Its up 6.23% from 4.54M shares, reported previously. With 1.20 million shares average volume, it will take short sellers 4 days to cover their ZBH’s short positions. The short interest to Zimmer Biomet Holdings Incorporated’s float is 2.42%. The stock increased 0.01% or $0.01 on November 21, hitting $102.09. Zimmer Biomet Holdings Inc (NYSE:ZBH) has declined 11.10% since April 20, 2016 and is downtrending. It has underperformed by 15.66% the S&P500.

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The company has a market cap of $20.42 billion. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It has a 57.13 P/E ratio. The Firm manages its activities through three geographic operating divisions: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets.

Zimmer Biomet Holdings Inc (NYSE:ZBH) Ratings Coverage

Out of 16 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 12 rate it a “Buy”, 1 “Sell”, while 3 “Hold”. This means 75% are positive. Zimmer Biomet Holdings has been the topic of 24 analyst reports since August 27, 2015 according to StockzIntelligence Inc. On Tuesday, August 2 the stock rating was maintained by UBS with “Neutral”. Barclays Capital maintained Zimmer Biomet Holdings Inc (NYSE:ZBH) rating on Friday, April 29. Barclays Capital has “Overweight” rating and $135 price target. Credit Suisse initiated Zimmer Biomet Holdings Inc (NYSE:ZBH) on Friday, October 9 with “Outperform” rating. Needham upgraded Zimmer Biomet Holdings Inc (NYSE:ZBH) on Tuesday, November 1 to “Strong Buy” rating. Nomura initiated Zimmer Biomet Holdings Inc (NYSE:ZBH) on Thursday, March 17 with “Buy” rating. Needham maintained it with “Buy” rating and $129 target price in Friday, January 29 report. The rating was initiated by Suntrust Robinson on Thursday, August 11 with “Buy”. The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) earned “Neutral” rating by Northcoast on Tuesday, November 8. RBC Capital Markets maintained Zimmer Biomet Holdings Inc (NYSE:ZBH) rating on Monday, November 2. RBC Capital Markets has “Outperform” rating and $120.0 price target. The rating was maintained by Needham on Friday, July 29 with “Buy”.

ZBH Company Profile

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., incorporated on January 12, 2001, is engaged in designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma (S.E.T.) products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Firm manages its activities through three geographic operating divisions: the Americas, comprising principally of the United States and includes other North, Central and South American markets; EMEA, comprising of principally of Europe and includes the Middle East and African markets, and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company’s four product category divisions include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic (CMF) and Dental.

More notable recent Zimmer Biomet Holdings Inc (NYSE:ZBH) news were published by: Wsj.com which released: “Zimmer Biomet Cuts Forecasts” on October 31, 2016, also Reuters.com with their article: “BRIEF-Seikagaku signs exclusive distribution agreement with Zimmer Biomet …” published on November 08, 2016, Prnewswire.com published: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” on November 01, 2016. More interesting news about Zimmer Biomet Holdings Inc (NYSE:ZBH) were released by: Prnewswire.com and their article: “ZIMMER BIOMET (ZBH) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP …” published on November 02, 2016 as well as Prnewswire.com‘s news article titled: “Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction …” with publication date: November 17, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marguerite Chambers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>